Newly Onset Dyspnea During Pregnancy
- PMID: 41073041
- DOI: 10.1016/j.chest.2025.05.040
Newly Onset Dyspnea During Pregnancy
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: The institution at which M. V. works has received payments for educational purposes from Boehringer Ingelheim and conference support from Sanofi. E. D. L. has received consulting fees from Amgen, Argenx, and GSK, honoraria from Actelion and Lilly, and conference support from Pfizer, Boehringer Ingelheim, Lilly, and MSD. E. D. L. has been on data safety monitoring or advisory boards of AC Immune, Boehringer Ingelheim, Amgen, AstraZeneca, GSK, Novartis, and Otsuka. E. D. L. is co-president of the Working Group Rare Diseases, Belgian Royal Society of Rheumatology. All payments have been made to the institution at which E. D. L. works. W. A. W. has received grants from Roche, Boehringer Ingelheim, Galapagos, and Alentis, all paid to the institution at which W. A. W. works. None declared (V. V. B., T. F., E. C., S. D. B., N. D. C., A. D., A. K., L. J. D. S.).
Publication types
LinkOut - more resources
Full Text Sources